ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 251 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $52,000 | -14.8% | 5,378 | -3.0% | 0.00% | – |
| Q3 2019 | $61,000 | -7.6% | 5,544 | -2.4% | 0.00% | -100.0% |
| Q2 2019 | $66,000 | +17.9% | 5,682 | -0.7% | 0.00% | – |
| Q1 2019 | $56,000 | +1.8% | 5,723 | +0.8% | 0.00% | -100.0% |
| Q4 2018 | $55,000 | -25.7% | 5,676 | +10.1% | 0.00% | 0.0% |
| Q3 2018 | $74,000 | +64.4% | 5,155 | +38.4% | 0.00% | 0.0% |
| Q2 2018 | $45,000 | -8.2% | 3,725 | -7.0% | 0.00% | 0.0% |
| Q1 2018 | $49,000 | -36.4% | 4,004 | -24.2% | 0.00% | 0.0% |
| Q4 2017 | $77,000 | 0.0% | 5,280 | -2.8% | 0.00% | 0.0% |
| Q3 2017 | $77,000 | +13.2% | 5,434 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $68,000 | -1.4% | 5,354 | -1.0% | 0.00% | 0.0% |
| Q1 2017 | $69,000 | +40.8% | 5,407 | +13.6% | 0.00% | 0.0% |
| Q4 2016 | $49,000 | +16.7% | 4,761 | +48.3% | 0.00% | 0.0% |
| Q3 2016 | $42,000 | +5.0% | 3,210 | -2.7% | 0.00% | 0.0% |
| Q2 2016 | $40,000 | – | 3,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |